In conclusion, IL-22-FP promotes liver regeneration in mice with predamaged livers following PHx and alleviates IRI-induced liver injury. Our study suggests that IL-22-FP may represent a promising therapeutic drug against regeneration deficiency and liver IRI in patients who have undergone PHx. PMID: 30515423 [PubMed - in process] (Source: Journal of Immunology Research)
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2G0SWS0
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.